iReadMore
ଆପ୍ ମଧ୍ୟରେ କ୍ରୟଗୁଡ଼ିକ
500+
ଡାଉନଲୋଡଗୁଡ଼ିକ
PEGI 3
info
ଏହି ଆପ୍ ବିଷୟରେ
iReadMore is a new reading therapy for improving single word reading ability.
It is for people with an acquired reading disorder (alexia) or aphasia due to a stroke, brain injury or dementia.
Start your 7 day free trial now!
iReadMore Features:
Adaptive Algorithm - iReadMore adapts to your abilities, keeping the therapy relevant and challenging.
Self-led Therapy - iReadMore allows you to be in control of your own therapy with unlimited access.
Science-Driven and Clinically-Proven Results - All of our rehabilitation therapies are developed through years of dedicated research at University College London by a team of scientists and clinicians.
Integrated Feedback - Complete reading tests and see your own progress.
iReadMore Research Summary:
- iReadMore therapy has been tested in two clinical trials. It was shown to improve reading ability in people with pure alexia (Woodhead et al., 2013) and central alexia (Woodhead et al., 2018)
- In the clinical trial of iReadMore for central alexia (the most common form of acquired reading disorder), the average improvement in reading accuracy was 8.7% for trained words. Three months after finishing the therapy, users still had significantly better reading ability than before they started.
- Anonymised results from the app will be collected to test how effective the app is and to improve our understanding of reading rehabilitation.
For more information and help getting started with iReadMore, please visit: https://www.ucl.ac.uk/icn/research/research-groups/neurotherapeutics/therapy-apps/ireadmore-app
If you have any other questions, please email us at ireadmore@ucl.ac.uk
iReadMore is a Class I CE marked medical device.
It is for people with an acquired reading disorder (alexia) or aphasia due to a stroke, brain injury or dementia.
Start your 7 day free trial now!
iReadMore Features:
Adaptive Algorithm - iReadMore adapts to your abilities, keeping the therapy relevant and challenging.
Self-led Therapy - iReadMore allows you to be in control of your own therapy with unlimited access.
Science-Driven and Clinically-Proven Results - All of our rehabilitation therapies are developed through years of dedicated research at University College London by a team of scientists and clinicians.
Integrated Feedback - Complete reading tests and see your own progress.
iReadMore Research Summary:
- iReadMore therapy has been tested in two clinical trials. It was shown to improve reading ability in people with pure alexia (Woodhead et al., 2013) and central alexia (Woodhead et al., 2018)
- In the clinical trial of iReadMore for central alexia (the most common form of acquired reading disorder), the average improvement in reading accuracy was 8.7% for trained words. Three months after finishing the therapy, users still had significantly better reading ability than before they started.
- Anonymised results from the app will be collected to test how effective the app is and to improve our understanding of reading rehabilitation.
For more information and help getting started with iReadMore, please visit: https://www.ucl.ac.uk/icn/research/research-groups/neurotherapeutics/therapy-apps/ireadmore-app
If you have any other questions, please email us at ireadmore@ucl.ac.uk
iReadMore is a Class I CE marked medical device.
ଗତ ଅପଡେଟର ସମୟ
ଡେଭେଲପରମାନେ ଆପଣଙ୍କ ଡାଟାକୁ କିପରି ସଂଗ୍ରହ ଏବଂ ସେୟାର କରନ୍ତି ସେହି ଧାରଣା ସହିତ ସୁରକ୍ଷା ଆରମ୍ଭ ହୁଏ। ଆପଣଙ୍କ ବ୍ୟବହାର, ଅଞ୍ଚଳ ଏବଂ ବୟସ ଆଧାରରେ, ଡାଟା ଗୋପନୀୟତା ଓ ସୁରକ୍ଷା କାର୍ଯ୍ୟପଦ୍ଧତିଗୁଡ଼ିକ ଭିନ୍ନ ହୋଇପାରେ। ଡେଭେଲପର ଏହି ସୂଚନା ପ୍ରଦାନ କରିଛନ୍ତି ଏବଂ ସେ ସମୟାନୁସାରେ ଏହାକୁ ଅପଡେଟ କରିପାରନ୍ତି।
ତୃତୀୟ ପକ୍ଷଗୁଡ଼ିକ ସହ କୌଣସି ଡାଟା ସେୟାର କରାଯାଇନାହିଁ
ଡେଭେଲପରମାନେ କିପରି ସେୟାରିଂର ଘୋଷଣା କରନ୍ତି ସେ ବିଷୟରେ ଅଧିକ ଜାଣନ୍ତୁ
ଏହି ଆପ ଏଇ ଡାଟା ପ୍ରକାରଗୁଡ଼ିକ ସଂଗ୍ରହ କରିପାରେ
ବ୍ୟକ୍ତିଗତ ସୂଚନା, ସ୍ୱାସ୍ଥ୍ୟ ଏବଂ ଫିଟନେସ, ଓ ଡିଭାଇସ କିମ୍ବା ଅନ୍ୟ IDଗୁଡ଼ିକ
ଟ୍ରାଞ୍ଜିଟ ସମୟରେ ଡାଟା ଏନକ୍ରିପ୍ଟ କରାଯାଇଥାଏ
ଡାଟା ଡିଲିଟ କରିଦିଆଯାଉ ବୋଲି ଆପଣ ଅନୁରୋଧ କରିପାରିବେ
ନୂଆ କଣ ଅଛି
Security update